Cancer Exercise Training Institute is categorized under Noncommercial Research Organizations in Portland, OR and active since 2013.
Cancer Exercise Training Institute was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 3436 Ne 21st Avenue, Portland, Oregon OR 97212 or by phoning (503) 502-6776. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cancer Exercise Training Institute |
Address: | 3436 Ne 21st Avenue, Portland, Oregon 97212 |
Phone Number: | (503) 502-6776 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Noncommercial Research Organizations |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Cancer Exercise Training Institute was started in 2013 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Cancer Exercise Training Institute by calling the company number (503) 502-6776, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Exercise Training Institute can be found at the coordinates 45.547802,-122.643985 as well as the street address 3436 Ne 21st Avenue in Portland, Oregon 97212.
For its online presence, you may visit Cancer Exercise Training Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.